ADMA Biologics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade ADMA Biologics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ADMA
ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate.
CEOAdam S. Grossman
CEOAdam S. Grossman
Employees685
Employees685
HeadquartersRamsey, New Jersey
HeadquartersRamsey, New Jersey
Founded2004
Founded2004
Employees685
Employees685
ADMA Key Statistics
Market cap4.26B
Market cap4.26B
Price-Earnings ratio21.00
Price-Earnings ratio21.00
Dividend yield—
Dividend yield—
Average volume1.82M
Average volume1.82M
High today$18.75
High today$18.75
Low today$17.45
Low today$17.45
Open price$18.38
Open price$18.38
Volume1.97M
Volume1.97M
52 Week high$25.67
52 Week high$25.67
52 Week low$13.50
52 Week low$13.50
Stock Snapshot
With a market cap of 4.26B, ADMA Biologics(ADMA) trades at $17.94. The stock has a price-to-earnings ratio of 21.00.
On 2026-01-04, ADMA Biologics(ADMA) stock moved within a range of $17.45 to $18.75. With shares now at $17.94, the stock is trading +2.8% above its intraday low and -4.3% below the session's peak.
Trading activity shows a volume of 1.97M, compared to an average daily volume of 1.82M.
Over the past 52 weeks, ADMA Biologics(ADMA) stock has traded between a high of $25.67 and a low of $13.50.
Over the past 52 weeks, ADMA Biologics(ADMA) stock has traded between a high of $25.67 and a low of $13.50.
People also own
Based on the portfolios of people who own ADMA. This list is generated using Robinhood data, and it’s not a recommendation.